Fig. 2From: Ultrasensitive bioassaying of HER-2 protein for diagnosis of breast cancer using reduced graphene oxide/chitosan as nanobiocompatible platformElectrode preparation steps. a The three consecutive ECL graphs of Bare, Bare + rGO-CS-Ru, Bare + rGO-CS-Ru + Ab and Bare + rGO-CS-Ru + Ab + HER-2; b correlated histograms of average ECL intensityBack to article page